ATC Group: J06BA01 Immunoglobulins, normal human, for extravascular adm.

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J06BA01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J06 Immune sera and immunoglobulins
3 J06B Immunoglobulins
4 J06BA Immunoglobulins, normal human
5 J06BA01 Immunoglobulins, normal human, for extravascular adm.

Related product monographs

Title Information Source Document Type  
CUTAQUIG Solution for infusion FDA, National Drug Code (US) MPI, US: SPL/PLR
CUVITRU Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
GAMASTAN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
GAMMANORM Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HIZENTRA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Malta (MT)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.